Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences

Globe Newswire 26-Feb-2025 4:05 PM

CHASKA, Minn., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that the company will participate in multiple upcoming investor conferences and industry events. Details regarding Lifecore's participation are as follows:

• TD Cowen 45^th Annual Health Care Conference
  
  Details: Paul Josephs, chief executive officer, will deliver a corporate presentation and Lifecore management will participate in investor meetings
  
  Presentation Date/Time: Tuesday, March 4, 2025, 9:50 – 10:20 a.m. ET
  
  Conference Dates: March 3-5, 2025
  
  Location: Boston, MA

• KeyBanc Capital Markets Healthcare Forum
  
  Details: Mr. Josephs will participate in a fireside chat and Lifecore management will participate in investor meetings
  
  Fireside Chat Date/Time: Wednesday, March 19, 2025, 3:00 – 3:35 p.m. ET
  
  Conference Dates: March 18-19, 2025
  
  Location: Virtual

• DCAT Week 2025
  
  Details: Lifecore team will participate in meetings with current and prospective customers and attend networking events
  
  Conference Dates: March 17-20, 2025
  
  Location: New York, NY

A live webcast of the TD Cowen presentation may be accessed via a link on Lifecore's investor website on the Investor Events & Presentations page at: https://ir.lifecore.com/events-presentations. Additionally, a replay of the webcast will be available on the Lifecore website following the conference. 

About Lifecore Biomedical

Lifecore Biomedical, Inc. (NASDAQ:LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore's website at www.lifecore.com.

Lifecore Biomedical, Inc. Contact Information:

Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
sdiaz@vidasp.com

Tim Brons (Media)
415-675-7402
tbrons@vidasp.com

Ryan D. Lake (CFO)
Lifecore Biomedical
952-368-6244
ryan.lake@lifecore.com